TXMD TherapeuticsMD Inc.

-0.18  -3%
Previous Close 5.19
Open 5.18
Price To Book 12.53
Market Cap 1208220843
Shares 241,161,845
Volume 2,099,999
Short Ratio
Av. Daily Volume 2,938,427

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

FDA approval announced October 29, 2018.
Moderate to severe vasomotor symptoms (VMS)
CRL announced May 8, 2017. NDA resubmitted with approval announced May 30, 2018.
Yuvvexy - TX-004HR
Moderate-to-severe vaginal pain
FDA Approval announced August 10, 2018.
Segesterone Acetate/ Ethinyl Estradiol

Latest News

  1. TherapeuticsMD Announces Oral and Poster Presentations on BIJUVA™ and ANNOVERA™ at the Endocrine Society 2019 Annual Meeting
  2. See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
  3. TherapeuticsMD Announces Oral Presentations on BIJUVA and ANNOVERA, and Poster Presentations Related to Menopause Symptoms and Treatments at 2019 ISSWSH/ISSM Joint Meeting
  4. Consolidated Research: 2019 Summary Expectations for TherapeuticsMD, Ensco plc, Cray, BeiGene, The Gap, and Nordson — Fundamental Analysis, Key Performance Indications
  5. Edited Transcript of TXMD earnings conference call or presentation 21-Feb-19 9:30pm GMT
  6. TherapeuticsMD Announces Participation in Two Upcoming Investor Conferences
  7. TherapeuticsMD (TXMD) Catches Eye: Stock Jumps 6.1%
  8. TherapeuticsMD, Inc. (TXMD) Q4 2018 Earnings Conference Call Transcript
  9. The Daily Biotech Pulse: BioMarin Slips On Earnings, TherapeuticsMD Posts In-Line Results, Orchard To Present Immunodeficiency Drug Data
  10. TherapeuticsMD: 4Q Earnings Snapshot
  11. TherapeuticsMD Announces Fourth Quarter and Full-Year 2018 Financial Results
  12. Is TherapeuticsMD, Inc.’s (NASDAQ:TXMD) Balance Sheet Strong Enough To Weather A Storm?
  13. TherapeuticsMD to Report Fourth Quarter and Full Year 2018 Results on February 21, 2019
  14. Here's What Pushed TherapeuticsMD 37.8% Higher in January
  15. Implied Volatility Surging for TherapeuticsMD (TXMD) Stock Options
  16. Why TherapeuticsMD's Stock Spiked Today
  17. TherapeuticsMD Announces Participation at 37th Annual J.P. Morgan Healthcare Conference